Nasdaq
COAG
Hemab Therapeutics Holdings, Inc.
- Health Care
- Listed 2026
- 1 day
- +4.1%
- 1 month
- +65.6%
- 1 year
- —
$52.16 · Mkt cap $2.44B
At the 6 Aug 2026 close
Nasdaq
Hemab Therapeutics Holdings, Inc.
$52.16 · Mkt cap $2.44B
At the 6 Aug 2026 close
Hemab Therapeutics Holdings, Inc. trades under the ticker COAG on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2026. Its market capitalisation is $2.44B. The last closing price was $52.16, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because COAG is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.